Cargando…
Focal cortical dysplasia type 1
The ILAE classification of Focal Cortical Dysplasia (FCD) from 2011 has quickly gained acceptance in clinical practice and research and is now widely used around the world. This histopathology‐based classification scheme proposed three subtypes, that is, FCD Type 1 (with architectural abnormalities...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412088/ https://www.ncbi.nlm.nih.gov/pubmed/34196986 http://dx.doi.org/10.1111/bpa.12964 |
_version_ | 1783747388897230848 |
---|---|
author | Coras, Roland Holthausen, Hans Sarnat, Harvey B. |
author_facet | Coras, Roland Holthausen, Hans Sarnat, Harvey B. |
author_sort | Coras, Roland |
collection | PubMed |
description | The ILAE classification of Focal Cortical Dysplasia (FCD) from 2011 has quickly gained acceptance in clinical practice and research and is now widely used around the world. This histopathology‐based classification scheme proposed three subtypes, that is, FCD Type 1 (with architectural abnormalities of the neocortex), FCD Type 2 (with cytoarchitectural abnormalities of the neocortex) and FCD Type 3 (architectural abnormalities of the neocortex associated with another principle lesion acquired during early life). Valuable knowledge was gathered during the last decade validating the clinical, pathological and genetic classification of FCD Type 2. This is in contrast to FCD subtype 1 and 3 with only few robust or new insights. Herein, we provide an overview about current knowledge about FCD Type 1 and its three subtypes. Available data strengthened, however, FCD Type 1A in particular, whereas a comprehensive clinico‐pathological specification for FCD Type 1B and 1C subtypes remain to be shown. The lack of a valid animal model for FCD Type 1 further supports our call and the ongoing need for systematic research studies based on a careful clinico‐pathological and genetic stratification of patients and human brain tissues. |
format | Online Article Text |
id | pubmed-8412088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84120882021-09-03 Focal cortical dysplasia type 1 Coras, Roland Holthausen, Hans Sarnat, Harvey B. Brain Pathol Mini‐symposium The ILAE classification of Focal Cortical Dysplasia (FCD) from 2011 has quickly gained acceptance in clinical practice and research and is now widely used around the world. This histopathology‐based classification scheme proposed three subtypes, that is, FCD Type 1 (with architectural abnormalities of the neocortex), FCD Type 2 (with cytoarchitectural abnormalities of the neocortex) and FCD Type 3 (architectural abnormalities of the neocortex associated with another principle lesion acquired during early life). Valuable knowledge was gathered during the last decade validating the clinical, pathological and genetic classification of FCD Type 2. This is in contrast to FCD subtype 1 and 3 with only few robust or new insights. Herein, we provide an overview about current knowledge about FCD Type 1 and its three subtypes. Available data strengthened, however, FCD Type 1A in particular, whereas a comprehensive clinico‐pathological specification for FCD Type 1B and 1C subtypes remain to be shown. The lack of a valid animal model for FCD Type 1 further supports our call and the ongoing need for systematic research studies based on a careful clinico‐pathological and genetic stratification of patients and human brain tissues. John Wiley and Sons Inc. 2021-07-01 /pmc/articles/PMC8412088/ /pubmed/34196986 http://dx.doi.org/10.1111/bpa.12964 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Mini‐symposium Coras, Roland Holthausen, Hans Sarnat, Harvey B. Focal cortical dysplasia type 1 |
title | Focal cortical dysplasia type 1 |
title_full | Focal cortical dysplasia type 1 |
title_fullStr | Focal cortical dysplasia type 1 |
title_full_unstemmed | Focal cortical dysplasia type 1 |
title_short | Focal cortical dysplasia type 1 |
title_sort | focal cortical dysplasia type 1 |
topic | Mini‐symposium |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412088/ https://www.ncbi.nlm.nih.gov/pubmed/34196986 http://dx.doi.org/10.1111/bpa.12964 |
work_keys_str_mv | AT corasroland focalcorticaldysplasiatype1 AT holthausenhans focalcorticaldysplasiatype1 AT sarnatharveyb focalcorticaldysplasiatype1 |